TAGS: Perfumes & Fragrances
Solvay and Anthea have concluded an agreement to establish a joint venture named CATàSYNTH Speciality Chemicals, dedicated to the production of catechol derivatives.
Joint Venture to Meet Market Demand
Through this joint venture, the two companies will work together to meet customers’ needs for additional, reliable supply for a range of products including methylenedioxybenzene, heliotropin (piperonal) and helional which are key ingredients for applications in the fragrance, pharma, flavor and agrochemical industries worldwide.
“
We have been producing synthetic heliotropin for the Flavors and Fragrances market since 2010 in Crown Chemicals, based on our patented manufacturing processes,” said Dr. Vincent Paul, founder & chairman of the Anthea Group.
To Expand Production Capacities
CATàSYNTH is currently completing a brand-new, world-class manufacturing facility in Mangalore, India which will be fully operational in Q1 2020.
“
Through this partnership with Solvay, we are significantly expanding our production capacities of methylenedioxybenzene and heliotropin, and also enlarging our product range to address other derivatives for the Agrochemical and Pharma market,” added Paul.
“
This partnership is fully aligned with our strategy to reinforce downstream integration. Solvay is committed to continue enlarging its product offer for the Flavor, Fragrance, Agrochemical and Pharma markets whilst ensuring excellent quality and security of supply,” commented Peter Browning, president of Solvay Aroma Performance GBU.
The closing of the deal is expected to occur early Q1 2020.
Source: Solvay